loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Carbapenem

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Carbapenem

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Venus Remedies receives Ukrainian GMP approval for Its parenteral facilities
    Venus Remedies receives Ukrainian GMP approval for Its parenteral facilities

    08 Jun 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/venus-remedies-receives-ukrainian-gmp-approval-for-its-carbapenem-oncology-parenteral-facilities-14238

    INDIAN PHARMA POST
    08 Jun 2023
    Share Share
    Venus Remedies gets good manufacturing certification from Saudi drug regulator
    Venus Remedies gets good manufacturing certification from Saudi drug regulator

    27 Feb 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-good-manufacturing-certification-from-saudi-drug-regulator/articleshow/98267076.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Feb 2023
    Share Share
    Venatorx, Roche Collaborate to Develop New Class of Antibiotics
    Venatorx, Roche Collaborate to Develop New Class of Antibiotics

    01 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211101005111/en

    BUSINESSWIRE
    01 Nov 2021
    Share Share
    Shionogi's APEKS-NP phase III trial of cefiderocol in patients
    Shionogi's APEKS-NP phase III trial of cefiderocol in patients

    05 Oct 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=118558&sid=2

    PHARMABIZ
    05 Oct 2019
    Share Share
    Shionogi to Present Data on Cefiderocol and Baloxavir Marboxil
    Shionogi to Present Data on Cefiderocol and Baloxavir Marboxil

    27 Sep 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180927005497/en

    BUSINESSWIRE
    27 Sep 2018
    Share Share
    AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
    AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3

    20 Aug 2018

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazeneca-spinout-entasis-files-for-86m-ipo-to-fund-antibiotic-phase-3

    Nick Paul Taylor FIERCE BIOTECH
    20 Aug 2018
    Share Share